← back to search

Anna Lia Molinari

Ospedale degli Infermi · IT
🔎 Find collaborators in Pathology and Forensic Medicine · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Parkinson's Disease Mechanisms and Treatments, and Neurological disorders and treatments.
h-index
20
citations
1,927
works
76
NIH funding
primary concept
Medicine
email

Recent publications

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Journal of Clinical Oncology 2024cited by 26position: middledoi
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology 2021cited by 266position: middledoi
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group
Hematological Oncology 2021cited by 11position: middledoi
POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL
Hematological Oncology 2021cited by 3position: middledoi
Efficacy of Idelalisib and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Treated Outside of Clinical Trial. a Report of the Gimema Group
Blood 2020cited by 0position: middledoi
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma
Hematological Oncology 2019cited by 84position: middledoi
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease
Neurology 2018cited by 73position: middledoi
Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death
British Journal of Haematology 2018cited by 70position: middledoi
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
The Lancet Oncology 2014cited by 183position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas L. Davis · University of Alabama at Birmingham Hospital1 papers (2018–2018) · 1 papers (2021–2021)Fenna T. Phibbs · Adaptive Design Association1 papers (2018–2018)Umberto Vitolo · Candiolo Cancer Institute1 papers (2014–2014)Rajat Bannerji · Rutgers Cancer Institute1 papers (2021–2021)Giorgio Inghirami · Cornell University1 papers (2014–2014)Giuseppe Gritti · Ospedale Papa Giovanni XXIII1 papers (2021–2021)Sam Yuen · Calvary Mater Newcastle Hospital1 papers (2021–2021)Kevin R. Cannard · Walter Reed National Military Medical Center1 papers (2018–2018)Mahlon R. DeLong · Emory University1 papers (2018–2018) · 1 papers (2014–2014)Jill L. Ostrem · San Francisco VA Medical Center1 papers (2018–2018) · 1 papers (2014–2014)Chris Arthur · Gilead Sciences (United States)1 papers (2021–2021)Marcello Gaudiano · Cornell University1 papers (2014–2014)Ileana Baldi · University of Padua1 papers (2014–2014)Peter Hedera · University of Louisville1 papers (2018–2018)J. Hirata · Gene Therapy Laboratory1 papers (2021–2021)Lisa Musick · Gene Therapy Laboratory1 papers (2021–2021)Maxim Turchan · Vanderbilt University Medical Center1 papers (2018–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Genetics →